Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung health
暂无分享,去创建一个
H. Zar | L. Myer | M. Nicol | M. Lesosky | W. Barnett | D. Gray | Polite Nduru | J. A. Stadler
[1] T. Cherian,et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting , 2020, Vaccine.
[2] Mark A. Miller,et al. Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood. , 2019, The Journal of infectious diseases.
[3] S. Madhi,et al. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study , 2019, The Lancet.
[4] C. Naaktgeboren,et al. RSV hospitalization in infancy increases the risk of current wheeze at age 6 in late preterm born children without atopic predisposition , 2019, European Journal of Pediatrics.
[5] O. Ramilo,et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. , 2018, The Lancet. Infectious diseases.
[6] J. Borghans,et al. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy. , 2018, Vaccine.
[7] R. Wood‐Baker,et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. , 2018, The Lancet. Respiratory medicine.
[8] Dan J Stein,et al. Associations between maternal mental health and early child wheezing in a South African birth cohort , 2018, Pediatric pulmonology.
[9] M. Rovers,et al. Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.
[10] Richard Beasley,et al. After asthma: redefining airways diseases , 2017, The Lancet.
[11] H. Zar,et al. Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure? , 2018, The Lancet. Respiratory medicine.
[12] T. Jartti,et al. Role of viral infections in the development and exacerbation of asthma in children , 2017, Journal of Allergy and Clinical Immunology.
[13] M. Lucero,et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study , 2017, The Lancet.
[14] L. Bont,et al. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood , 2017, Infectious Diseases and Therapy.
[15] Dan J Stein,et al. Lung Function in African Infants in the Drakenstein Child Health Study. Impact of Lower Respiratory Tract Illness , 2017, American journal of respiratory and critical care medicine.
[16] Dan J Stein,et al. Determinants of early-life lung function in African infants , 2016, Thorax.
[17] H. Zar,et al. Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study , 2016, The Lancet Respiratory Medicine.
[18] K. O'Brien,et al. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. , 2015, The Lancet. Infectious diseases.
[19] H. Zar,et al. Incidence of childhood pneumonia: facility-based surveillance estimate compared to measured incidence in a South African birth cohort study , 2015, BMJ Open.
[20] S. Madhi,et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta–analysis , 2015, Journal of global health.
[21] S. Guerra,et al. Pneumonia in Childhood and Impaired Lung Function in Adults: A Longitudinal Study , 2015, Pediatrics.
[22] T. Hartert,et al. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. , 2015, American journal of respiratory and critical care medicine.
[23] Dan J Stein,et al. Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study , 2014, Thorax.
[24] M. Rovers,et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. , 2013, The New England journal of medicine.
[25] R. Lemanske,et al. The Role of Respiratory Virus Infections in Childhood Asthma Inception , 2010, Immunology and Allergy Clinics of North America.
[26] H. Bisgaard,et al. Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins. , 2010, Chest.
[27] D. Duffy,et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. , 2009, American journal of respiratory and critical care medicine.
[28] David R. Williams,et al. Social determinants of psychological distress in a nationally-representative sample of South African adults. , 2008, Social science & medicine.
[29] H. Zar,et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13‐ to 14‐year‐old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III , 2007, Allergy.
[30] H. Whittle,et al. Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia. , 1999, The Journal of pediatrics.